12:00 AM
Nov 18, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gattex teduglutide regulatory update

NPS said FDA accepted for review an sNDA to update the label of Gattex teduglutide for short bowel syndrome (SBS) to include long-term data from the open-label STEPS 2 extension trial. The PDUFA date is June 28. STEPS 2 is an...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >